HIF1 alpha mediated angiogenesis and mammalian Target of Rapamycin (mTOR) activation: implications for treatment of tuberous sclerosis

Andrew Tee, S.C. Land, E. A. Dunlop, M. Davies, M. H. Shen, J. R. Sampson

    Research output: Contribution to journalBook/Film/Article reviewpeer-review

    Original languageEnglish
    Pages (from-to)S17
    Number of pages1
    JournalJournal of Medical Genetics
    Publication statusPublished - 2007

    Cite this